Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1965 1
1966 1
1971 2
1975 1
1977 1
1978 1
1979 2
1981 1
1982 1
1984 2
1985 1
1986 1
1987 1
1988 1
1989 2
1990 1
1991 2
1992 2
1993 2
1994 5
1995 4
1996 4
1997 7
1998 8
1999 5
2000 8
2001 19
2002 16
2003 22
2004 12
2005 18
2006 12
2007 16
2008 20
2009 14
2010 27
2011 24
2012 27
2013 39
2014 119
2015 175
2016 198
2017 196
2018 227
2019 213
2020 257
2021 316
2022 336
2023 375
2024 160

Text availability

Article attribute

Article type

Publication date

Search Results

2,611 results

Results by year

Filters applied: . Clear all
Page 1
Neurovascular interaction.
Takarada-Iemata M, Westenskow PD, Muramatsu R. Takarada-Iemata M, et al. Neurochem Int. 2019 Oct;129:104506. doi: 10.1016/j.neuint.2019.104506. Epub 2019 Jul 16. Neurochem Int. 2019. PMID: 31323247 No abstract available.
Peter Riederer, a translational neurobiochemist.
Nagatsu T, Reichmann H. Nagatsu T, et al. J Neural Transm (Vienna). 2022 Jun;129(5-6):443-444. doi: 10.1007/s00702-022-02497-2. Epub 2022 Apr 7. J Neural Transm (Vienna). 2022. PMID: 35389106 No abstract available.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT. Schuster SJ, et al. Lancet Oncol. 2021 Oct;22(10):1403-1415. doi: 10.1016/S1470-2045(21)00375-2. Epub 2021 Sep 10. Lancet Oncol. 2021. PMID: 34516954 Clinical Trial.
METHODS: In this multicentre, open-label, single-arm, phase 2 trial (JULIET) done at 27 treatment sites in ten countries (Australia, Austria, Canada, France, Germany, Italy, Japan, the Netherlands, Norway, and the USA), adult patients (18 years) with histologically confirm …
METHODS: In this multicentre, open-label, single-arm, phase 2 trial (JULIET) done at 27 treatment sites in ten countries (Australia, Austria …
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
METHODS: In this open-label, international, phase 3, randomised controlled trial, we recruited patients with relapsed or refractory mycosis fungoides or Sezary syndrome at 61 medical centres in the USA, Denmark, France, Italy, Germany, the Netherlands, Spain, Switzerland, the UK, …
METHODS: In this open-label, international, phase 3, randomised controlled trial, we recruited patients with relapsed or refractory mycosis …
Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
Gosavi R, Chia C, Michael M, Heriot AG, Warrier SK, Kong JC. Gosavi R, et al. Int J Colorectal Dis. 2021 Oct;36(10):2063-2070. doi: 10.1007/s00384-021-03945-3. Epub 2021 May 4. Int J Colorectal Dis. 2021. PMID: 33945007 Review.
Most studies had NAC completion rates of above 83% with two notable exceptions being Zhou et al. and The Colorectal Cancer Chemotherapy Study Group of Japan who both recorded a completion rate of 52%. Time to surgery from completion of NAC ranged on average from 16 to 31 d …
Most studies had NAC completion rates of above 83% with two notable exceptions being Zhou et al. and The Colorectal Cancer Chemotherapy Stud …
Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche.
Emoto T, Lu J, Sivasubramaniyam T, Maan H, Khan AB, Abow AA, Schroer SA, Hyduk SJ, Althagafi MG, McKee TD, Fu F, Shabro S, Ulndreaj A, Chiu F, Paneda E, Pacheco S, Wang T, Li A, Jiang JX, Libby P, Husain M, Wang B, Rubin BB, Cybulsky MI, Robbins CS. Emoto T, et al. Immunity. 2022 May 10;55(5):862-878.e8. doi: 10.1016/j.immuni.2022.04.005. Epub 2022 May 3. Immunity. 2022. PMID: 35508166 Free article.
Tacalcitol.
Peters DC, Balfour JA. Peters DC, et al. Drugs. 1997 Aug;54(2):265-71; discussion 272. doi: 10.2165/00003495-199754020-00005. Drugs. 1997. PMID: 9257082 Review.
Tacalcitol is a vitamin D3 analogue which is available in Japan as a 2 micrograms/g ointment for twice daily application and in Western markets as a 4 micrograms/g ointment for once daily application. ...
Tacalcitol is a vitamin D3 analogue which is available in Japan as a 2 micrograms/g ointment for twice daily application and in Weste …
2,611 results